HC Wainwright keeps Buy on Tyra Biosciences, targets $29
HC Wainwright & Co. maintained a Buy rating on Tyra Biosciences and reiterated a $29.00 price target, implying 13.1% upside versus the Sep 21 close of $25.65.
HC Wainwright & Co. maintained a Buy rating on Tyra Biosciences and reiterated a $29.00 price target, implying 13.1% upside versus the Sep 21 close of $25.65.